FDA Clears Self-Administered Lupus Therapy - Quiz - MDSpire

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

  • By

  • Kathryn Wighton

  • April 28, 2026

  • 2 min

Share

Original Source(s)

FDA Clears Self-Administered Lupus Therapy

  • by Kathryn Wighton

  • April 28, 2026

Related Content

Dupilumab Gains Pediatric CSU Approval

Targets type 2 inflammation in a population with limited treatment options

Correction: Clinical significance of erythrocyte sedimentation rate-based stratification in a large retrospective SLE cohort

Cross-disease immune cells atlas reveals the similarities and differences of cell characteristics and interactions in rheumatic diseases